PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia VeraBusiness Wire • 06/25/24
Tri-Continental Corporation Announcements Regarding 94th Annual Meeting of StockholdersBusiness Wire • 03/14/24
Tri-Continental Corporation Announcements Regarding 93rd Annual Meeting of StockholdersBusiness Wire • 03/10/23
Tri-Continental Corporation Announcements Regarding 92nd Annual Meeting of StockholdersBusiness Wire • 03/11/22
Tri-Continental: A Solid Balanced Fund With A Good Long-Term Performance RecordSeeking Alpha • 11/01/21
Tri-Continental Corporation Announcements Regarding 91st Annual Meeting of StockholdersBusiness Wire • 03/22/21